Combination cancer treatment comprising an oncolytic HSV and a Receptor Tyrosine Inhibitor of a VEGFR

摘要

A method of treating cancer is disclosed, the method comprising simultaneous or sequential administration of a virus and a receptor tyrosine kinase (RTK) inhibitor.